Results 31 to 40 of about 48,868 (199)

Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees

open access: yesBMC Medical Ethics, 2021
Background This paper highlights the issues that one of the 90 Italian Research Ethics Committees (RECs) might encounter during the approval phase of a clinical trial to identify corrective and preventive actions for promoting a more efficient review ...
G. Benfatto   +3 more
doaj   +1 more source

Pharmacovigilance during mass immunization campaign with MenAfrivac τm in Cameroon [PDF]

open access: yes, 2015
Background. Immunization is one of the most cost effective public health interventions and is estimated to have greatly reduced diseases, disabilities, deaths, and inequities worldwide.
Ateudjieu, Jerome
core   +1 more source

The risk of preterm labor after COVID-19 vaccination before and during pregnancy

open access: yesFrontiers in Drug Safety and Regulation, 2023
Background: Pregnant women have a higher risk of severe illness and adverse pregnancy outcomes due to a SARS-CoV-2 infection. COVID-19 vaccination can prevent (severe) infection.
M. de Feijter   +5 more
doaj   +1 more source

Clinical characteristics and risk factors for cefaclor-induced immediate hypersensitivity: a retrospective observation at two university hospitals in Korea

open access: yesAllergy, Asthma & Clinical Immunology, 2021
Background Cefaclor, a second-generation oral cephalosporin, is widely prescribed to treat infectious diseases. Immediate hypersensitivity (HS) reactions to cefaclor have continuously been reported and are expected to increase with its greater use.
Hyo-In Rhyou   +8 more
doaj   +1 more source

Designing adverse event forms for real-world reporting: participatory research in Uganda. [PDF]

open access: yes, 2012
The wide-scale roll-out of artemisinin combination therapies (ACTs) for the treatment of malaria should be accompanied by continued surveillance of their safety.
Clare I R Chandler   +37 more
core   +2 more sources

Correction to: Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees

open access: yesBMC Medical Ethics, 2021
An amendment to this paper has been published and can be accessed via the original article.
G. Benfatto   +3 more
doaj   +1 more source

Medication errors safety signals COVID-19-related Moroccan Pv database [PDF]

open access: yesE3S Web of Conferences, 2021
On March 23, 2020, the Moroccan Ministry of Health issued a circular authorizing the off label use of hydroxychloroquine or chloroquine in combination with azythromycin as first-line treatment for all COVID-19 patients. The aim of this study is to detect,
Sefiani Houda   +3 more
doaj   +1 more source

An evaluation of postmarketing reports of hyperglycaemia associated with dolutegravir for treatment of HIV in Eswatini

open access: yesAIDS Research and Therapy, 2022
Background Dolutegravir (DTG) is an Integrase Strand Transfer Inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV infection.
Alemayehu L. Duga   +5 more
doaj   +1 more source

Hospital doctors' views and concerns about pharmacovigilance [PDF]

open access: yes, 2015
Purpose: The aim of the study was to evaluate the opinions and concerns of hospital doctors about adverse drug reactions (ADRs) and pharmacovigilance.
Pedrós, Consuelo   +7 more
core   +1 more source

Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study

open access: yesJournal of Pharmaceutical Policy and Practice, 2022
Background Upon the authorization of COVID-19 vaccines worldwide, national and international standards were developed to help integrate mass COVID-19 immunization campaigns into the healthcare network.
Abeer Zeitoun   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy